During the course of previous insulin autoantibody (IAA) workshops [1] [2] [3] it had become apparent that fluid phase (RIA) and solid phase (ELISA) antibody detection assays gave discordant results for many sera. It was therefore decided to compare the disease association of IAA as determined by RIA vs ELISA in the Fourth IAA Workshop.
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For this purpose 31 participating laboratories submitted unselected sera obtained from healthy control subjects (n = 61), from patients with newly diagnosed Type 1 (insulin-dependent) diabetes mellitus (n = 30) prior to or within 24 h after the first insulin injection, and from relatives of Type I diabetic patients (n = 30). The sera were aliquoted and distributed by the Immunology of Diabetes Workshops (IDW) Laboratory in Gainesville, USA. Results from 18 fluid phase and from 10 solid phase assays could be included in the analysis. In both assays sera were tested twice, before and after competitive inhibition with excess insulin. Absolute counts of immunoglobulin bound iodinated insulin or absolute optical densities and/or displaceable "specific" signals (delta % binding or delta optical density) were submitted. The distribution of displaceable signals obtained with the 61 normal sera is shown in Figure 1 for two representative laboratories and no relevant differences were observed between the fluid phase and solid phase assays. RIA and ELISA gave similarly rare positive readings with control sera. Most of the RIA laboratories (16 of 18; 89%) read none or only one control sera as being above 3 SD for all controls and 7 of 10 (70%) laboratories determined 0 or 1 control sera as above 3 SD by ELISA. Signals higher than 5 SD were detected in none of the control sera by RIA and in one serum by 2 (20%) out of 10 ELISAs. 3-16.7) by ELISA. This in part reflects higher background and a corresponding variation of signals for control sera in ELISA, i.e. both the mean signal in normal sera and the mean variance, are higher in ELISA assays (Fig. 2) . Because of the higher specific signal and the concomitantly greater number of positive results in patient sera it was concluded that fluid phase assays were superior to solid phase assays for identifying disease associated IAA signals.
There was little difference in the height of the specific signal obtained by the various RIAs for a given serum, classification of sera as positive or negative largely dependend on the relation of the signal to the 3 SD cut off, i. e., RIAs with small variation of signals in control sera had a small mean SD. This led to a lower cut off and higher SD scores for IAA positive sera. Most of the radiobinding assay characteristics were identical or closely related to recently published methods [4] [5] [6] and are summarized in Table 1 Acknowledgements. We thank members of the participating laboratories, in particular Drs. L. Castano and J. C. Sodoyez for the discussion of results. 
